These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12517018)

  • 1. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
    Walder B; Pittet D; Tramèr MR
    Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
    Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
    Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
    Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review.
    Niël-Weise BS; Stijnen T; van den Broek PJ
    J Hosp Infect; 2008 Jun; 69(2):114-23. PubMed ID: 18439717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
    Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
    JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of prolonging the use of central venous catheters: a prospective analysis of the effects of using antiseptic-bonded catheters with daily site care.
    Norwood S; Wilkins HE; Vallina VL; Fernandez LG; McLarty JW
    Crit Care Med; 2000 May; 28(5):1376-82. PubMed ID: 10834681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project.
    Collin GR
    Chest; 1999 Jun; 115(6):1632-40. PubMed ID: 10378561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?
    Saint S; Veenstra DL; Lipsky BA
    Infect Control Hosp Epidemiol; 2000 Jun; 21(6):375-80. PubMed ID: 10879567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
    Veenstra DL; Saint S; Sullivan SD
    JAMA; 1999 Aug; 282(6):554-60. PubMed ID: 10450717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.
    Marciante KD; Veenstra DL; Lipsky BA; Saint S
    Am J Infect Control; 2003 Feb; 31(1):1-8. PubMed ID: 12548250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing catheter-related infection and hospital costs by continuous quality improvement.
    Civetta JM; Hudson-Civetta J; Ball S
    Crit Care Med; 1996 Oct; 24(10):1660-5. PubMed ID: 8874302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.
    Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV
    Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.